The ability of PNX to regulate lipid metabolism through these conserved pathways underscores its versatility and significance as potential therapeutic applications in maintaining metabolic health conditions such as obesity. Here, SMIM20 is linked to obesity due to melanocortin 4 receptor deficiency.